Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

By sjmartinez • January 3, 2025

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA; HPTN 084 Study Team. Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401. PMID: 39748218.

Tags: Cabotegravir, HIV prevention, Infectious Diseases, long‐acting, pregnancy, PrEP, Publications, Women

Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV

Fairlie L, Brummel S, Ziemba L, Coletti A, Chinula L, Shapiro R, Stringer J, Malonga G, Browning R, Chakhtoura N, Mmbaga BT, Mhembere TP, Omoz-Oarhe[...]

Telemedicine for HIV care: a cross-sectional survey of people living with HIV receiving care at two federally qualified health centers in Los Angeles during a mature phase of the COVID-19 pandemic

Walker D, Moucheraud C, Butler D, Takayama C, Shoptaw S, Currier JS, Gladstein J, Hoffman R. Telemedicine for HIV care: a cross-sectional survey of people[...]

Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus

Li Y, Mishra NN, Chen L, Manna AC, Cheung AL, Proctor RA, Xiong YQ. Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility[...]